Clinical Trial Update: Sedation Efficacy and Safety of Remazolam Besylate in Ventilated Surgical Critically Ill Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the sedation efficacy and safety of Remazolam Besylate in ventilated, critically ill surgical patients; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Illness

Drugs mentioned

• Remazolam Besylate (remazolam besylate)

Snippet

Sponsor: Beijing Shijitan Hospital, Capital Medical University | Conditions: Effect of Drug, Adverse Drug Event | Phase 4 | Status: RECRUITING